Nonrulemaking

Withdrawn From Sale of Tylosterone Tablets

🏛 Food and Drug Administration (FDA)FDA-1998-P-0083

Pharmaceutical Policy Product Safety & Recalls

Documents

21

Total comments

13

all analyzed

Comment status

Closed

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 21 Other 17 Notice 3 Supporting & Related Material 1

Notice· Jun 26, 2026
Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661→
No comment period
Notice· May 27, 2026
Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation 7661→
Notice· Apr 16, 2003
Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing→
💬 13